OrphanDrug
OrphanDrug
Pharma Knowledge Base

body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency

MeSH: C563654ORPHA: 91135

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency is a very rare genetic skin disease characterized by severe skin laxity affecting the trunk and limbs

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency, sourced from HPO and Orphanet clinical annotations.

Cutis laxaRedundant skinAbnormality of coagulationPapuleAngioid streaksAbnormal bleedingAtherosclerosisDilatation of the cerebral artery

Classification & Codes

MeSH Code

C563654

Orphanet Code

ORPHA:91135
body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency
MeSHC563654
OrphanetORPHA:91135
Treatments0 drug(s)
Symptoms on record8 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO